The goal is to quickly incorporate the best available research, along with clinical experience ... or national conference. Poster and podium presentation templates are available in our Inquiry Toolkit ...

Ruvindu Perera, cell and molecular biology graduate student, placed first in the Foodborne Pathogens and Contaminants in Animal-Based Products category. Amanda Anthney, poultry science graduate ...

PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free technology, today announced their upcoming poster presentation on November ...

but do not stretch or modify the master brand mark or crest within the template. Print your poster on campus. For best results, print your research poster through University Print Services. This is UB ...

will deliver a poster presentation at the ACR Convergence 2024 Annual Meeting, which will be held in Washington, D.C., November 14-19, 2024. A copy of the Company’s presentation will be available ...

Atea Pharmaceuticals (AVIR) announced it presented three poster presentations supporting the combination of bemnifosbuvir and ruzasvir as a potential treatment for hepatitis C virus, or HCV.

today announced an upcoming poster presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting, being held from November 6-10, 2024 in Houston, Texas. Building on its deep ...

The use of PowerPoint to create posters is the weapon of choice for smart researchers. Choose from this selection of horizontally and vertically oriented PowerPoint shows with branded backgrounds, or ...

There will also be several didactic programs that are jointly administered with other summer research programs at CWRU and CSU. These may include scientific seminars, research presentations, and ...

PharmaJet Poster Presentation at Cancer Immunotherapy Conference Highlights How Needle-free Technology is Enhancing Oncology ...

UAB Printing and Mailing recently installed a new state-of-the-art color offset digital press. While the print shop has been ...

- Initial data from the ongoing Phase 1b study evaluating R289, a dual IRAK1/4 inhibitor, in LR-MDS Initial data from the dose escalation phase using a July 15, 2024 data cutoff date indicate that ...